Reprimands, complaints up compared to previous quarter
The VPA conducted 20 panel hearings in the first three months of this year alone, with 12 of these resulting in a reprimand and eight in a caution The Victorian …
Biologic treatment for severe asthma listed on PBS
A new pre-filled autoinjector for at-home administration of mepolizumab will be reimbursed by the PBS from 1 June Patients with severe refractory eosinophilic asthma can now choose to receive treatment …
Rural pharmacies fill gap left by doctor shortages
Temporary measures allowing community pharmacists to provide one-month supply of a patient’s regular medication when they can’t get a script should be made permanent, argues rural group While COVID-19 and …
Combination inhaler PBS listed for mild asthma
Symbicort is now PBS-listed for any form of asthma severity – mild, moderate or severe. So how should this change your conversations with patients asking for an OTC blue puffer? …
‘It’s essential that people feel safe to speak up.’
What’s the best way to support your pharmacy team during the pandemic? A recent webinar from AJP and PSS provides some valuable advice This week AJP and the Pharmacists’ Support …
Pharma companies fined $4.5m over product claims
They admitted to making false or misleading representations in the marketing of two pain relief products GlaxoSmithKline Consumer Healthcare Australia and Novartis Consumer Health Australasia have been ordered to pay …
April PBS data shows spike in demand
There was a sharp rise in overall scripts processed in April compared to the same time last year, with particularly high demand for respiratory medicines Newly released data shows there …
“The Mask Man” pharmacist charged with price gouging
A US pharmacist, who is alleged to have bought $300k worth of N95 masks and sold them at inflated prices, will face federal court over charges of hoarding, price gouging …
‘Are there any ways of avoiding this demise?’
A pharmacist has signalled concerns about the “demise of community pharmacy” in the UK Community pharmacy may be under significant threat having been “damningly considered” as an “incomplete profession” over …
WHO hits ‘pause’ on trial
The international health organisation has temporarily suspended the hydroxychloroquine arm within its COVID-19 treatment trial in light of recent findings World Health Organization director-general Tedros Adhanom Ghebreyesus has confirmed the …
Incoming 7CPA crucial for pharmacy viability
The next five years will be critical to lay the foundation for change, say pharmacists The 7CPA and the government’s 10-year Primary Health Care Plan will determine the profession’s sustainability …
‘Urgent confirmation from randomised clinical trials is needed.’
A large observational study has linked hydroxychloroquine and chloroquine use to increased rates of mortality and heart arrhythmias in hospitalised COVID-19 patients A large observational study published in The Lancet has …